Pharmacogenetics of Lithium Long-Term Treatment: Focus on Initiation and Adaptation Mechanisms, Neuropsychobiology, vol.62, issue.1, pp.61-71, 2010. ,
DOI : 10.1159/000314311
Psychiatric genetics: search for phenotypes, Trends in Neurosciences, vol.21, issue.3, pp.102-105, 1998. ,
DOI : 10.1016/S0166-2236(97)01187-9
Investigating responders to lithium prophylaxis as a strategy for mapping susceptibility genes for bipolar disorder, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.29, issue.6, pp.1038-1045, 2005. ,
DOI : 10.1016/j.pnpbp.2005.03.021
Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine, Bipolar Disorders, vol.54, issue.2, pp.110-114, 2003. ,
DOI : 10.1016/0165-1781(87)90064-3
Reconsideration of bipolar disorder as a developmental disorder: Importance of the time of onset, Journal of Physiology-Paris, vol.107, issue.4, 2013. ,
DOI : 10.1016/j.jphysparis.2013.03.006
URL : https://hal.archives-ouvertes.fr/inserm-00811691
The phenotypic spectra of bipolar disorder, European Neuropsychopharmacology, vol.14, pp.94-99, 2004. ,
DOI : 10.1016/j.euroneuro.2004.03.006
Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP, Psychiatry Research, vol.73, issue.3, pp.159-171, 1997. ,
DOI : 10.1016/S0165-1781(97)00123-6
Extreme discordant phenotype methodology: an intuitive approach to clinical pharmacogenetics, European Journal of Pharmacology, vol.410, issue.2-3, pp.107-120, 2000. ,
DOI : 10.1016/S0014-2999(00)00809-8
Statistical power of association using the extreme discordant phenotype design, Pharmacogenetics and Genomics, vol.16, issue.6, pp.401-413, 2006. ,
DOI : 10.1097/01.fpc.0000204995.99429.0f
A double-blind comparison of lithium carbonate and maprotiline in the prophylaxis of the affective disorders, The British Journal of Psychiatry, vol.128, issue.5, pp.479-485, 1976. ,
DOI : 10.1192/bjp.128.5.479
Prediction of affective psychoses response to lithium prophylaxis., Acta Psychiatrica Scandinavica, vol.34, issue.1538, pp.37-44, 1984. ,
DOI : 10.1007/BF00427807
Treatment-refractory bipolar disorder: classification to aid in clinical management, Expert Opinion on Pharmacotherapy, vol.56, issue.12, pp.1907-1915, 2009. ,
DOI : 10.1001/archpsyc.60.11.1079
A haplotype-based study of lithium responding patients with bipolar affective disorder on the Faroe Islands, Psychiatric Genetics, vol.9, issue.4, pp.23-34, 1999. ,
DOI : 10.1097/00041444-199912000-00010
Lithium responsive bipolar disorder, unilineality, and chromosome 18: A linkage study, American Journal of Medical Genetics, vol.17, issue.4, pp.411-415, 1999. ,
DOI : 10.1002/(SICI)1096-8628(19990820)88:4<411::AID-AJMG20>3.0.CO;2-9
Suggestive linkage of a chromosomal locus on 18p11 to cyclothymic temperament in bipolar disorder families, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, vol.117, issue.3 ,
DOI : 10.1002/ajmg.b.30601
Genome-wide search for linkage of bipolar affective disorders in a very large pedigree derived from a homogeneous population in Quebec points to a locus of major effect on chromosome 12q23-q24, American Journal of Medical Genetics, vol.2, issue.5, pp.567-587, 1999. ,
DOI : 10.1002/(SICI)1096-8628(19991015)88:5<567::AID-AJMG24>3.0.CO;2-8
A genome-wide scan points to a susceptibility locus for bipolar disorder on chromosome 12, Molecular Psychiatry, vol.21, issue.6, pp.545-552, 2005. ,
DOI : 10.1002/(SICI)1096-8628(19970531)74:3<247::AID-AJMG3>3.3.CO;2-#
Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based on excellent response to lithium, Molecular Psychiatry, vol.6, issue.5, pp.570-578, 2001. ,
DOI : 10.1038/sj.mp.4000888
Implication of synapse-related genes in bipolar disorder by linkage and gene expression analyses, The International Journal of Neuropsychopharmacology, vol.13, issue.10, pp.13-1397, 2010. ,
DOI : 10.1017/S1461145710000714
Gene-expression studies in understanding the mechanism of action of lithium, Expert Review of Neurotherapeutics, vol.12, issue.1, pp.93-97, 2012. ,
DOI : 10.1586/ern.11.184
A common mechanism of action for three mood-stabilizing drugs, Nature, vol.80, issue.6886, pp.292-295, 2002. ,
DOI : 10.1083/JCB.136.6.1287
The polymorphic inositol polyphosphate 1- phosphatase gene as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness, Pharmacogenetics, vol.8, issue.3, pp.259-268, 1998. ,
Association study of the INPP1, 5HTT, BDNF, AP-2?? and GSK-3?? GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder, Neuroscience Letters, vol.403, issue.3, pp.288-293, 2006. ,
DOI : 10.1016/j.neulet.2006.05.001
Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatment, The Pharmacogenomics Journal, vol.5, issue.1, pp.35-41, 2005. ,
DOI : 10.1038/sj.tpj.6500273
Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder, Molecular Psychiatry, vol.9, issue.6, pp.621-629, 2004. ,
DOI : 10.1038/sj.mp.4001460
Lack of genetic variation in the coding region of the myo-inositol monophosphatase gene in lithium-treated patients with manic depressive illness, Pharmacogenetics, vol.6, issue.1, pp.113-116, 1996. ,
DOI : 10.1097/00008571-199602000-00010
A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder, Molecular Psychiatry, vol.69, issue.2, pp.197-207, 2008. ,
DOI : 10.1016/j.cell.2006.03.032
Interacting genes in lithium prophylaxis: preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 ,
The diacylglycerol kinase eta gene and bipolar disorder: a replication study in a Sardinian sample, Molecular Psychiatry, vol.447, issue.4, pp.350-351, 2009. ,
DOI : 10.1038/mp.2008.16
Evidence for a role of phospholipase C-??1 in the pathogenesis of bipolar disorder, Molecular Psychiatry, vol.3, issue.6, pp.534-538, 1998. ,
DOI : 10.1038/sj.mp.4000447
Identification of three polymorphisms in the translated region of PLC-?1 and their investigation in lithium responsive bipolar disorder, American Journal of Medical Genetics, vol.3, issue.3, pp.301-305, 2001. ,
DOI : 10.1002/ajmg.1326
The phospholipase C-??1 gene (PLCG1) and lithium-responsive bipolar disorder: re-examination of an intronic dinucleotide repeat polymorphism, Psychiatric Genetics, vol.11, issue.1, pp.41-43, 2001. ,
DOI : 10.1097/00041444-200103000-00008
Inhibition of GSK3 by lithium, from single molecules to signaling networks, Frontiers in Molecular Neuroscience, vol.5, p.14, 2012. ,
DOI : 10.3389/fnmol.2012.00014
A glycogen synthase kinase 3-?? promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression, Neuroscience Letters, vol.368, issue.2, pp.123-126, 2004. ,
DOI : 10.1016/j.neulet.2004.06.050
Association study of the glycogen synthase kinase-3?? gene polymorphism with prophylactic lithium response in bipolar patients, The World Journal of Biological Psychiatry, vol.38, issue.1, pp.158-161, 2006. ,
DOI : 10.1034/j.1399-5618.2002.40201.x
Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock, Science, issue.5763, pp.311-1002, 2006. ,
?? Circadian Gene Variants and Lithium Carbonate Prophylaxis in Bipolar Affective Disorder, Journal of Biological Rhythms, vol.311, issue.2, pp.132-137, 2010. ,
DOI : 10.1177/0748730410362713
pathway and lithium response in the treatment of bipolar disorder, Genes, Brain and Behavior, vol.311, issue.Suppl. 5, pp.852-861, 2011. ,
DOI : 10.1111/j.1601-183X.2011.00725.x
Glucocorticoid receptor polymorphism is associated with lithium response in bipolar patients, Neuro Endocrinol. Lett, vol.32, issue.4, pp.545-551, 2011. ,
Dopamine receptor D2 and D4 genes, GABAA alpha-1 subunit gene and response to lithium prophylaxis in mood disorders, Psychiatry Research, vol.87, issue.1, pp.7-19, 1999. ,
DOI : 10.1016/S0165-1781(99)00056-6
Dopamine receptor D3 gene and response to lithium prophylaxis in mood disorders, The International Journal of Neuropsychopharmacology, vol.1, issue.2, pp.125-129, 1998. ,
DOI : 10.1017/S1461145798001230
Serotonin receptor 2A, 2C, 1A genes and response to lithium prophylaxis in mood disorders, Journal of Psychiatric Research, vol.34, issue.2, pp.89-98, 2000. ,
DOI : 10.1016/S0022-3956(00)00004-2
Serotonin transporter gene associated with lithium prophylaxis in mood disorders, The Pharmacogenomics Journal, vol.151, issue.1, pp.71-77, 2001. ,
DOI : 10.1093/nar/19.19.5444
Response to lithium prophylaxis: Interaction between serotonin transporter andBDNF genes, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, vol.20, issue.6, pp.144-820, 2007. ,
DOI : 10.1002/ajmg.b.30420
No association between lithium full responders and the DRD1, DRD2, DRD3, DAT1, 5-HTTLPR and HTR2A genes in a Sardinian sample, Psychiatry Research, vol.169, issue.2, pp.164-166, 2009. ,
DOI : 10.1016/j.psychres.2008.12.004
Dopamine D1 Receptor Gene Polymorphism is Associated with Prophylactic Lithium Response in Bipolar Disorder, Pharmacopsychiatry, vol.42, issue.01, pp.20-22, 2009. ,
DOI : 10.1055/s-0028-1085441
Association studies of 5-HT2A and 5-HT2C serotonin receptor gene polymorphisms with prophylactic lithium response in bipolar patients, Pharmacol Rep, vol.57, issue.6, pp.761-765, 2005. ,
Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders, The Pharmacogenomics Journal, vol.4, issue.4, pp.267-273, 2004. ,
DOI : 10.1038/sj.tpj.6500252
Prophylactic effect of lithium in bipolar affective illness may be related to serotonin transporter genotype, Pharmacol Rep, vol.57, issue.1, pp.124-127, 2005. ,
Association and linkage studies of candidate genes involved in GABAergic neurotransmission in lithium-responsive bipolar disorder, J Psychiatry Neurosci, vol.25, issue.4, pp.353-358, 2000. ,
Pharmacogenetics of lithium prophylaxis in mood disorders: Analysis of COMT, MAO-A, and G?3 variants, American Journal of Medical Genetics, vol.11, issue.4, pp.370-379, 2002. ,
DOI : 10.1002/ajmg.10357
MAOA, Psychiatric Genetics, vol.9, issue.1, pp.13-16, 1999. ,
DOI : 10.1097/00041444-199903000-00003
Tryptophan hydroxylase gene and response to lithium prophylaxis in mood disorders11This work was partially supported by the BIOMED 2 grant BMH4-CT97-2307., Journal of Psychiatric Research, vol.33, issue.5, pp.371-377, 1999. ,
DOI : 10.1016/S0022-3956(99)00013-8
Lithium-responsive affective disorders: no association with the tyrosine hydroxylase gene, Psychiatry Research, vol.64, issue.2, pp.91-96, 1996. ,
DOI : 10.1016/0165-1781(96)02888-0
Prophylactic Lithium Response and Polymorphism of the Brain-Derived Neurotrophic Factor Gene, Pharmacopsychiatry, vol.38, issue.4, pp.166-170, 2005. ,
DOI : 10.1055/s-2005-871239
gene polymorphisms with prophylactic lithium response in bipolar patients, Pharmacogenomics, vol.9, issue.11, pp.1595-1603, 2008. ,
DOI : 10.2217/14622416.9.11.1595
Lithium response and Val66Met polymorphism of the brain-derived neurotrophic factor gene in Japanese patients with bipolar disorder, Psychiatric Genetics, vol.16, issue.2, pp.49-50, 2006. ,
DOI : 10.1097/01.ypg.0000180680.72922.57
polymorphisms with prophylactic lithium response in bipolar patients, Human Psychopharmacology: Clinical and Experimental, vol.1003, issue.4, pp.287-291, 2009. ,
DOI : 10.1002/hup.1018
No association of three GRIN2B polymorphisms with lithium response in bipolar patients, Pharmacological Reports, vol.61, issue.3, pp.448-452, 2009. ,
DOI : 10.1016/S1734-1140(09)70085-4
Lithium response and genetic variation in the CREB family of genes, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, vol.8, issue.4, pp.500-504, 2008. ,
DOI : 10.1002/ajmg.b.30617
No association between the PREP gene and lithium responsive bipolar disorder, BMC Psychiatry, vol.18, issue.1, 2007. ,
DOI : 10.1093/emboj/18.10.2734
Lithium response and [minus sign]116C/G polymorphism of XBP1 in Japanese patients with bipolar disorder, The International Journal of Neuropsychopharmacology, vol.8, issue.04, pp.631-632, 2005. ,
DOI : 10.1017/S146114570500533X
A possible association between the [minus sign]116C/G single nucleotide polymorphism of the XBP1 gene and lithium prophylaxis in bipolar disorder, The International Journal of Neuropsychopharmacology, vol.9, issue.01, pp.83-88, 2006. ,
DOI : 10.1017/S1461145705005523
A possible association between missense polymorphism of the breakpoint cluster region gene and lithium prophylaxis in bipolar disorder, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.32, issue.1, pp.204-208, 2008. ,
The PDLIM5 gene and lithium prophylaxis: An association and gene expression analysis in Sardinian patients with bipolar disorder, Pharmacological Research, vol.57, issue.5, pp.369-373, 2008. ,
DOI : 10.1016/j.phrs.2008.03.011
Stargazin involvement with bipolar disorder and response to lithium treatment, Pharmacogenetics and Genomics, vol.18, issue.5, pp.403-412, 2008. ,
DOI : 10.1097/FPC.0b013e3282f974ca
The Pharmacogenetics of Lithium Response Depends upon Clinical Co-Morbidity, Molecular Diagnosis & Therapy, vol.100, issue.16, pp.161-170, 2007. ,
DOI : 10.1007/BF03256238
Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene and response to lithium prophylaxis in bipolar patients, Human Psychopharmacology: Clinical and Experimental, vol.99, issue.2, pp.168-171, 2011. ,
DOI : 10.1002/hup.1182
Clinical and pathogenic aspects of candidate genes for lithium prophylactic efficacy, Journal of Psychopharmacology, vol.116, issue.3, pp.368-373, 2012. ,
DOI : 10.1177/0269881111415736
The International Consortium on Lithium Genetics (ConLiGen): An Initiative by the NIMH and IGSLI to Study the Genetic Basis of Response to Lithium Treatment, Neuropsychobiology, vol.62, issue.1, pp.72-78, 2010. ,
DOI : 10.1159/000314708
A Genomewide Association Study of Response to Lithium for Prevention of Recurrence in Bipolar Disorder, American Journal of Psychiatry, vol.166, issue.6, pp.718-725, 2009. ,
DOI : 10.1176/appi.ajp.2009.08111633
gene variant with response to lithium treatment in Sardinian patients with bipolar disorder, Pharmacogenomics, vol.12, issue.11, pp.12-1559, 2011. ,
DOI : 10.2217/pgs.11.102
A Survey of Genomic Studies Supports Association of Circadian Clock Genes with Bipolar Disorder Spectrum Illnesses and Lithium Response, PLoS ONE, vol.150, issue.2, p.32091, 2012. ,
DOI : 10.1371/journal.pone.0032091.s003
Preliminary evidence on the association between XBP1-116C/G polymorphism and response to prophylactic treatment with valproate in bipolar disorders, Psychiatry Research, vol.168, issue.3, pp.209-212, 2009. ,
DOI : 10.1016/j.psychres.2008.05.010
Catechol-O-methyltransferase Val158Met polymorphism affects therapeutic response to mood stabilizer in symptomatic manic patients, Psychiatry Research, vol.175, issue.1-2, pp.63-66, 2010. ,
DOI : 10.1016/j.psychres.2008.09.011
Genetic Association Study of Treatment Response With Olanzapine/Fluoxetine Combination or Lamotrigine in Bipolar I Depression, The Journal of Clinical Psychiatry, vol.71, issue.05, pp.599-605, 2010. ,
DOI : 10.4088/JCP.08m04632gre
Use of antipsychotic drugs and lithium in mania, The British Journal of Psychiatry, vol.178, issue.41, pp.148-156, 2001. ,
DOI : 10.1192/bjp.178.41.s148
Association of Common Variations in the Norepinephrine Transporter Gene With Response to Olanzapine-Fluoxetine Combination Versus Continued-Fluoxetine Treatment in Patients With Treatment-Resistant Depression, The Journal of Clinical Psychiatry, vol.73, issue.06, pp.878-885, 2012. ,
DOI : 10.4088/JCP.10m06744
Influence of the catechol-O-methyltransferase Val108/158Met polymorphism on the plasma concentration of catecholamine metabolites and on clinical features in type I bipolar disorder--a preliminary report Key Words: Bipolar disorder, Pharmacogenomics, Pharmacogenetics, Mood Stabilizer, Lithium, Review Send correspondence to, J Affect Disord, vol.9223, pp.277-2813314981329033149813099, 2006. ,